We have revealed that PRL-3 can induce EMT through PTEN downregulation (Wang et al., 2007) and can lead to drug resistance of AML, implying the possibility of PRL-3 in tumor stem-like cell transition. This evidence concerns the gene PTP4A3 and neoplasm.